Universe Pharmaceuticals (UPC) Notes Payables (2020 - 2025)

Universe Pharmaceuticals (UPC) has 6 years of Notes Payables data on file, last reported at $7.1 billion in Q3 2025.

• For the quarter ending Q3 2025, Notes Payables rose 22.08% year-over-year to $7.1 billion; the trailing twelve-month figure through Sep 2025 stood at $7.1 billion (up 22.08% YoY), and the FY2025 full-year result was $7.1 billion, up 22.08% from the prior year.
• Notes Payables rose to $7.1 billion in Q3 2025, from $5.9 billion in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $7.1 billion in Q3 2025 to a low of $3.9 million in Q3 2022.
• A 5-year average of $1.6 billion and a median of $4.4 million in 2022 frame the typical range for Notes Payables.
• Across the five-year window, Notes Payables plunged 100.0% in 2021 and surged 106726.27% in 2024, its largest moves.
• Tracing UPC's Notes Payables over 5 years: stood at $4.3 million in 2021, then declined by 9.19% to $3.9 million in 2022, then jumped by 39.28% to $5.5 million in 2023, then surged by 106726.27% to $5.9 billion in 2024, then climbed by 22.08% to $7.1 billion in 2025.
• Business Quant data shows UPC's Notes Payables at $7.1 billion in Q3 2025, $5.9 billion in Q3 2024, and $4.4 million in Q1 2024.